Business
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
"In the second quarter of 2025, we further improved our operational performance as strong organic revenue growth and double-digit operating income growth put us fully on track to deliver our full year 2025 financial outlook", said Helen Giza, Chief Executive Officer of Fresenius Medical Care AG. "Organic revenue growth of 7% was supported by all operating segments. The overall phasing of earnings in the first half of the year developed in line with our planning. Strong profitability gains in Car
About this update from Fresenius Medical Care Ag
[{"type":"list","items":[{"val":[{"type":"text","content":"Strong organic revenue growth1 of 7% driven by all operating segments","length":69,"tagName":"p"}]},{"val":[{"type":"text","content":"Stable U.S. same market treatment development driven by accelerating patient inflow","length":83,"tagName":"p"}]},{"val":[{"type":"text","content":"FME25+ savings of EUR 58 million contributed to earnings","length":56,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating income2 grew by 13% at constant currency, further driving margin expansion","length":84,"tagName":"p"}]},{"val":[{"type":"text","content":"Stable reported operating income and 20% increase in reported net income3","length":73,"tagName":"p"}]},{"val":[{"type":"text","content":"Operating cash flow improved strongly by 75%, net leverage ratio improved to 2.7x","length":81,"tagName":"p"}]},{"val":[{"type":"text","content":"FY 2025 outlook confirmed","length":25,"tagName":"p"}]},{"val":[{"type":"text","content":"First tranche of announced share buyback to be initiated in August","length":66,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":537,"olType":false},{"type":"text","content":"BAD HOMBURG, Germany, Aug. 5, 2025 /PRNewswire/ -- "In the second quarter of 2025, we further improved our operational performance as strong organic revenue growth and double-digit operating income growth put us fully on track to deliver our full year 2025 financial outlook", said Helen Giza, Chief Executive Officer of Fresenius Medical Care AG. "Organic revenue growth of 7% was supported by all operating segments. The overall phasing of earnings in the first half of the year developed in line with our planning. Strong profitability gains in Care Enablement led to double-digit operating income growth. Care Delivery also drove improvements in operating income and margin, despite flat U.S. volume development. We remain encouraged by the strong and accelerating momentum in patient referrals that continued in the second quarter. However, this positive development in patient inflow was offset by higher-than-expected patient outflow driven by continued elevated mortality and a greater number of missed treatments following the severe flu season in the first months of the year. In the second half of the year, we expect to realize further significant operational and financial improvements." Giz...